Highlights Eli Lilly and Company

Equities

LLY

US5324571083

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			After market 07:14:38 pm
733.5 ^USD	+1.19%		734	+0.07%

Apr. 25	Scholz pledges further support for the pharmaceutical industry	DP
Apr. 25	Scholz promises support for pharma sector in Germany as Merck invests	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Scholz pledges further support for the pharmaceutical industry	Apr. 25	DP
Scholz promises support for pharma sector in Germany as Merck invests	Apr. 25	RE
Alexandria Real Estate's Q1 FFO rises on stronger occupancy rates	Apr. 22	RE
Eli Lilly Acquires Injectables Manufacturing Facility in Wisconsin from Nexus Pharmaceuticals	Apr. 22	MT
Eli Lilly to acquire manufacturing facility from Nexus Pharma	Apr. 22	RE
Eli Lilly and Company entered into a definitive agreement to acquire New Injectable Medicine Manufacturing Facility of Nexus Pharmaceuticals, Inc.	Apr. 21	CI
India's Biocon developing its own version of Wegovy, clinical trial likely next year	Apr. 18	RE
Top Stories at Midday: U.S. Bancorp, Abbott, Citizens Financial, First Horizon, Prologis, ASML, Travelers Report Earnings; Tesla Asks Shareholders Vote on Musk's Compensation; Eli Lilly Sleep Apnea Drug Trials Hit Primary Endpoints	Apr. 17	MT
Trending : Eli Lilly Weight-Loss Drug Works on Sleep Apnea	Apr. 17	DJ
Wall St slips as dour earnings, chip stocks weigh	Apr. 17	RE
Global markets live: LVMH, ASML, Rio Tinto, Eli Lilly, Tesla...	Apr. 17
Eli Lilly's Weight-loss Drug Improves Sleep Apnea Symptoms in Late-stage Studies	Apr. 17	MT
Sector Update: Health Care Stocks Advance Premarket Wednesday	Apr. 17	MT
The market is pinning its hopes on earnings reports	Apr. 17
Eli Lilly's Phase 3 Trials of Tirzepatide to Treat Sleep Apnea Meet Endpoints	Apr. 17	MT
Eli Lilly: positive data in sleep apnea	Apr. 17	CF
Studies Show Eli Lilly Weight-Loss Drug Helps With Sleep Apnea	Apr. 17	DJ
Eli Lilly's weight-loss drug succeeds in trials with sleep apnea patients	Apr. 17	RE
Eli Lilly and Company Announces Positive Topline Results of the Surmount-OSA Phase 3 Clinical Trials	Apr. 17	CI
Precision BioSciences Opts to Regain Rights to 3 Programs From Eli Lilly Unit Collaboration	Apr. 16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT